Lori A Rinckel

age ~63

from Clayton, NC

Get Report

Also known as:

Lori Ann Rinckel
Lori Living Rinckel
Lori Ann Rinckel Living
Lori A Rinkel

Phone and address:: 571 Lee Rd, Clayton, NC 27520

Connected to:

Lori Rinckel Phones & Addresses

571 Lee Rd, Clayton, NC 27520
571 Lee Rd APT K, Clayton, NC 27520
Stroudsburg, PA
Four Oaks, NC
Bartonsville, PA
Cary, NC
Swiftwater, PA
Knoxville, TN
Smithfield, NC

Work

Company:

Takeda pharmaceuticals
2014
Position:

Associate director | laboratory technical services | vaccine business unit

Education

Degree:

Doctorates, Doctor of Philosophy
School / High School:

University of Illinois

Skills

Biotechnology • Assay Development • Validation • Gmp • Fda • Technology Transfer • Vaccines • Microbiology • Glp • Molecular Biology • Protein Chemistry • In Vitro • Cell • Pcr • Lifesciences • Qpcr • Toxicology • Immunology • Nucleic Acid • Enzyme Assays • Genetics • Biochemistry • Column Chromatography • Biopharmaceuticals • Virology • High Throughput Screening • Cell Biology • Monoclonal Antibodies • Sop • Lims • Laboratory • Cell Culture • Regulatory Submissions • Drug Development • Infectious Diseases • Clinical Development • Immunoassays • Hplc • Medical Devices • Chromatography • Purification • Clinical Trials • Drug Discovery • Elisa • Immunoprecipitation • Science • In Vivo • Genomics • Protein Purification • Pharmacology

Languages

English • Japanese • French

Ranks

Certificate:

Project Managament Professional (Pmp)

Emails

l***[email protected]

Industries

Biotechnology

Name / Title

Company / Classification

Phones & Addresses

Lori A. Rinckel
Vice-President

Bray's Advanced Collision Repair, Inc
Auto Body Repair/Painting

99 Rte 611, Bartonsville, PA 18321
5704267204

Resumes

Associate Director | Laboratory Technical Services | Vaccine Business Unit

view source

Location:

690 west Olive Rd, Clayton, NC 27520

Industry:

Biotechnology

Work:

Takeda Pharmaceuticals
Associate Director | Laboratory Technical Services | Vaccine Business Unit
Integrated Laboratory Systems 2011 - 2013
Principal Investigator | Niceatm Government Contract
Grifols 2005 - 2011
Section Head | Nucleic Acid Technology Development
Sanofi Pasteur 1999 - 2005
Director | Analytical Sciences and Assay Development
University of Maryland 1997 - 1999
Postdoctoral Fellow | Infectious Diseases

Education:

University of Illinois
Doctorates, Doctor of Philosophy University of Illinois
Master of Science, Masters Wake Technical Community College
University of Illinois at Urbana - Champaign
Doctorates, Doctor of Philosophy, Microbiology University of Illinois at Urbana - Champaign
Master of Science, Masters, Microbiology University of Tennessee, Knoxville
Xavier University
Bachelors, Bachelor of Science, Biology

Skills:

Biotechnology
Assay Development
Validation
Gmp
Fda
Technology Transfer
Vaccines
Microbiology
Glp
Molecular Biology
Protein Chemistry
In Vitro
Cell
Pcr
Lifesciences
Qpcr
Toxicology
Immunology
Nucleic Acid
Enzyme Assays
Genetics
Biochemistry
Column Chromatography
Biopharmaceuticals
Virology
High Throughput Screening
Cell Biology
Monoclonal Antibodies
Sop
Lims
Laboratory
Cell Culture
Regulatory Submissions
Drug Development
Infectious Diseases
Clinical Development
Immunoassays
Hplc
Medical Devices
Chromatography
Purification
Clinical Trials
Drug Discovery
Elisa
Immunoprecipitation
Science
In Vivo
Genomics
Protein Purification
Pharmacology

Languages:

English
Japanese
French

Certifications:

Project Managament Professional (Pmp)
Six Sigma Champion

Us Patents

Human Erythrovirus
view source
US Patent:

20100196875, Aug 5, 2010
Filed:

Jan 15, 2008
Appl. No.:

12/523309
Inventors:

Douglas C. Lee - Apex NC, US
Todd M. Gieman - Cary NC, US
Chris Glenn - Holly Springs NC, US
Burton Beams - Raleigh NC, US
Brett Buno - Durham NC, US
Lori Rinckel - Clayton NC, US
Assignee:

Talecris Biotherapeutics, Inc. - Research Triangle Park NC
International Classification:

C12Q 1/70
C07H 21/04
C12N 7/01
US Classification:

435 5, 536 231, 4352351
Abstract:

Nucleic acid molecules derived from sequences of novel human parvovirus B19 variant genomes are provided. Also provided are assays and kits comprising the nucleic acid molecules.

Methods, Nucleic Acids, And Kits For Detection Of Parvovirus B19
view source
US Patent:

20140106337, Apr 17, 2014
Filed:

Oct 14, 2013
Appl. No.:

14/053245
Inventors:

- RESEARCH TRIANGLE PARK NC, US
TODD M. GIERMAN - CARY NC, US
CHRIS GLENN - HOLLY SPRINGS NC, US
BURTON BEAMS - RALEIGH NC, US
BRETT BUNO - DURHAM NC, US
LORI RINCKEL - CLAYTON NC, US
Assignee:

GRIFOLS THERAPEUTICS INC. - RESEARCH TRIANGLE PARK NC
International Classification:

C12Q 1/70
US Classification:

435 5, 536 2433
Abstract:

Nucleic acid molecules derived from sequences of novel human parvovirus B19 variant genomes are provided. Also provided are assays and kits comprising the nucleic acid molecules.